No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)
Here's Why You Should Retain Nevro Stock in Your Portfolio Now
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
RBC Capital Maintains Nevro(NVRO.US) With Hold Rating, Maintains Target Price $5.85
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Wave Life Sciences (WVE) and Nevro Corp (NVRO)
Nevro Reports Q4 Revenue Beat, but Wider Loss Than Expected